Literature DB >> 1854566

Thrombolytic treatment in acute myocardial infarction: neutrophil activation, peripheral leucocyte responses, and myocardial injury.

K Ranjadayalan1, V Umachandran, S W Davies, D Syndercombe-Court, C N Gutteridge, A D Timmis.   

Abstract

OBJECTIVE: To examine early leucocyte responses and neutrophil activation in acute myocardial infarction treated by streptokinase and to relate the findings to coronary recanalisation and indices of myocardial damage in order to provide further information about the role of neutrophils in the evolution of injury.
DESIGN: Group analysis of paired blood samples, obtained before streptokinase treatment and one hour after it, and of three indirect measures of myocardial injury: left ventricular ejection fraction, QRS score, and peak creatine kinase.
SETTING: The coronary care unit of a district general hospital. PATIENTS: 39 patients with acute myocardial infarction who underwent paired blood sampling (before streptokinase and one hour after streptokinase) and cardiac catheterisation 5 (3-8) days later. END POINTS: Changes in peripheral white cell and neutrophil counts and plasma elastase one hour after streptokinase infusion. Comparison of these variables in patients with and without patency of the infarct related coronary artery. Correlations between these variables and indirect measures of myocardial injury.
RESULTS: Neutrophil activation, as reflected by plasma elastase, increased sharply one hour after streptokinase. Total white cell and neutrophil counts also increased. Changes tended to be more pronounced in patients with patency of the infarct related artery, though the trend was not statistically significant. Neutrophil activation before streptokinase was unrelated to indirect indices of myocardial injury but only one hour after streptokinase a weak negative correlation with left ventricular ejection fraction had developed. Peripheral neutrophil responses showed a similar relation to ejection fraction and also correlated with peak creatine kinase and QRS score.
CONCLUSIONS: Thrombolytic treatment in acute myocardial infarction is associated with an abrupt reactive neutrophil response which provides an early measure of injury. It is also associated with neutrophil activation, probably in response to coronary recanalisation and myocardial reperfusion. Activated neutrophils are recognised as mediators of reperfusion injury in experimental infarction and the data in the present study provide preliminary evidence of a similar pathogenic role in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854566      PMCID: PMC1024556          DOI: 10.1136/hrt.66.1.10

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  25 in total

1.  EXPERIMENTAL ACUTE MYOCARDIAL INFARCTION; HISTOLOGIC AND HISTOCHEMICAL STUDIES OF EARLY MYOCARDIAL INFARCTS INDUCED BY TEMPORARY OR PERMANENT OCCLUSION OF A CORONARY ARTERY.

Authors:  H M SOMMERS; R B JENNINGS
Journal:  Lab Invest       Date:  1964-12       Impact factor: 5.662

2.  Hemodynamic spectrum of myocardial infarction and cardiogenic shock. A conceptual model.

Authors:  H J Swan; J S Forrester; G Diamond; K Chatterjee; W W Parmley
Journal:  Circulation       Date:  1972-05       Impact factor: 29.690

3.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man.

Authors:  H Sandler; H T Dodge
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

4.  Chemotactic activity in the coronary sinus after experimental myocardial infarction: effects of pharmacologic interventions on ischemic injury.

Authors:  J R Hartmann; J A Robinson; R M Gunnar
Journal:  Am J Cardiol       Date:  1977-10       Impact factor: 2.778

Review 5.  Role of neutrophils in ischemic heart disease: pathophysiologic role in myocardial ischemia and coronary artery reperfusion.

Authors:  B R Lucchesi
Journal:  Cardiovasc Clin       Date:  1987

6.  Observations on the diagnostic and prognostic value of some enzyme tests in myocardial infarction.

Authors:  O Kibe; N J Nilsson
Journal:  Acta Med Scand       Date:  1967-11

7.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

8.  Imaging the inflammatory response to acute myocardial infarction in man using indium-111-labeled autologous platelets.

Authors:  R A Davies; M L Thakur; H J Berger; F J Wackers; A Gottschalk; B L Zaret
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

9.  Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.

Authors:  J Mehta; P Mehta; D L Lawson; N Ostrowski; L Brigmon
Journal:  J Lab Clin Med       Date:  1985-09

10.  A QRS scoring system for assessing left ventricular function after myocardial infarction.

Authors:  S T Palmeri; D G Harrison; F R Cobb; K G Morris; F E Harrell; R E Ideker; R H Selvester; G S Wagner
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

View more
  5 in total

1.  An increase in plasma concentrations of granulocyte elastase during and after bench surgery of the liver.

Authors:  K Irita; T Taniyama; H Okamoto; H Inoue; M Umeki; S Inaba; S Taniguchi; Y Sakaguchi; K Mazuda; M Yamakawa; J Yoshitake; S Takahashi
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

2.  Neutrophil and Platelet Activity and Quantification Following Delayed tPA Therapy in a Rabbit Model of Thromboembolic Stroke.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

3.  Increased levels of plasma thrombomodulin in patients with acute myocardial infarction who had thrombolytic therapy and achieved successful reperfusion.

Authors:  M Ileri; I Hisar; E Yetkin; F Koşar; S Cehreli; S Korkmaz; D Demirkan
Journal:  Clin Cardiol       Date:  2001-05       Impact factor: 2.882

4.  Free radical activity and left ventricular function after thrombolysis for acute infarction.

Authors:  S W Davies; K Ranjadayalan; D G Wickens; T L Dormandy; V Umachandran; A D Timmis
Journal:  Br Heart J       Date:  1993-02

5.  Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents.

Authors:  K Riesenberg; F Schlaeffer; A Katz; R Levy
Journal:  Br Heart J       Date:  1995-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.